MENU

These 3 small cap ASX shares are on the rise on Wednesday

The local share market has bounced back from its heavy declines and is pushing higher on Wednesday.

Three small cap shares that have caught the eye with notable gains today are listed below. Here’s why they are on the rise:

The Eden Innovations Ltd (ASX: EDE) share price has rocketed 31% higher to 9.3 cents. Its shares have been on fire in October after announcing its first Federal funded highway repair project in the United States. The contract will see the company’s EdenCrete admixture product used to replace numerous sections of concrete pavement along 11 miles of the Interstate Highway I-16 in Twiggs County. Management estimates that the contract is worth US$525,000 in revenue. Considering how much its shares have now climbed, I suspect that investors are betting on this being the first of many contract wins.

The iSentia Group Ltd (ASX: ISD) share price has climbed over 3% to 33.5 cents despite there being no news out of the media monitoring company. But with its shares down a massive 81% over the last 12 months and hovering just above a 52-week low, I wouldn’t be surprised if bargain hunters are swooping in. While its shares do look cheap, I’m not convinced that iSentia is over the worst of its problems and would suggest investors stay clear of the company until its performance improves.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has pushed over 3% higher to 79.5 cents after the clinical-stage biopharmaceutical company announced a strategic collaboration agreement with the largest private provider of oncology services in Australia and Europe, GenesisCare. The agreement covers three major collaboration areas. These include the establishment of a preferred clinical provider relationship for running radiation oncology studies in Australia, a partnership to deliver compassionate use access to Telix’s glioblastoma therapy program across its extensive patient network, and the joint exploration of the commercial potential of Telix’s products in China. I think Telix is one to watch.

Missed these gains? Then don't miss out on this small cap tech share tipped for big things.

ASX Small Cap Tech Share – Real Winner from the World Cup

Earlier this year, millions of Australians set alarms and watched the world's biggest sporting event, the World Cup, play out. But did you know there was another Australian representative quietly succeeding as the world watched?

It's the start-up who have positioned themselves as the global leader in sports analytics. Motley Fool's resident tech expert has already upgraded the recommendation of this company's stock to a rating of simply "Buy More".

Click here to access this share. It's completely FREE!

Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia has recommended iSentia Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!